IMS Health to Issue Second-Quarter 2012 Financial Results on July 30, Conference Call for Note Holders Scheduled for August 2

IMS Health to Issue Second-Quarter 2012 Financial Results on July 30, Conference Call for Note Holders Scheduled for August 2

<0> IMS HealthTammy Tobin, 203-448-4663Investor Relations </0>

IMS Health plans to post for note holders its second-quarter 2012 financial results on Monday, July 30, 2012. The company will conduct a conference call for IMS's note holders to review these results at 1:00 p.m. ET on Thursday, August 2, 2012. To obtain additional details for accessing the company's results and joining the conference call, note holders should e-mail .

IMS Health is a leading provider of information, services and technology for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, sophisticated analytics, on-shore and off-shore commercial services, and software platforms to help clients better understand the performance and dynamics of healthcare systems. With a presence in 100+ countries and more than 55 years of industry experience, IMS serves leading decision makers in healthcare, including pharmaceutical manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at .

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.